HEADER TRANSCRIPTION 25-JUN-18 6A5Y TITLE CRYSTAL STRUCTURE OF HUMAN FXR/RXR-LBD HETERODIMER BOUND TO HNC143 AND TITLE 2 9CRA AND SRC1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BILE ACID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: FARNESOID X-ACTIVATED RECEPTOR,FARNESOL RECEPTOR HRR-1, COMPND 6 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4,RETINOID X RECEPTOR- COMPND 7 INTERACTING PROTEIN 14,RXR-INTERACTING PROTEIN 14; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 12 CHAIN: B, F; COMPND 13 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 17 CHAIN: D; COMPND 18 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 2 GROUP B MEMBER 1,RETINOID X COMPND 19 RECEPTOR ALPHA; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H4, BAR, FXR, HRR1, RIP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 GENE: RXRA, NR2B1; SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 21 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3) KEYWDS NUCLEAR RECEPTOR, HETERODIMER, COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR N.WANG,J.LIU REVDAT 4 27-MAR-24 6A5Y 1 REMARK REVDAT 3 05-DEC-18 6A5Y 1 JRNL REVDAT 2 17-OCT-18 6A5Y 1 COMPND JRNL REVDAT 1 10-OCT-18 6A5Y 0 JRNL AUTH N.WANG,Q.ZOU,J.XU,J.ZHANG,J.LIU JRNL TITL LIGAND BINDING AND HETERODIMERIZATION WITH RETINOID X JRNL TITL 2 RECEPTOR ALPHA (RXR ALPHA ) INDUCE FARNESOID X RECEPTOR JRNL TITL 3 (FXR) CONFORMATIONAL CHANGES AFFECTING COACTIVATOR BINDING JRNL REF J. BIOL. CHEM. V. 293 18180 2018 JRNL REFN ESSN 1083-351X JRNL PMID 30275017 JRNL DOI 10.1074/JBC.RA118.004652 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 32442 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1665 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2356 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 122 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3746 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.15000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : -0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.204 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.402 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3930 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3751 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5315 ; 1.799 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8712 ; 1.079 ; 2.980 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 464 ; 5.999 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 189 ;37.261 ;23.810 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 732 ;15.594 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;18.430 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.121 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4235 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 763 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6A5Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1300008201. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JAN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.29 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34177 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 83.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.10 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 0.88400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE , 0.1M TRI REMARK 280 -SODIUM CITRATE,25%PEG 4000, PH 5.6, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.81500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.69000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.40750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.69000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 121.22250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.69000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.69000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.40750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.69000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.69000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 121.22250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 80.81500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU B 744 REMARK 465 ARG B 745 REMARK 465 GLY B 756 REMARK 465 SER B 757 REMARK 465 PRO B 758 REMARK 465 SER B 759 REMARK 465 SER D 225 REMARK 465 ALA D 226 REMARK 465 ASN D 227 REMARK 465 PRO D 244 REMARK 465 LYS D 245 REMARK 465 THR D 246 REMARK 465 GLU D 247 REMARK 465 THR D 248 REMARK 465 TYR D 249 REMARK 465 VAL D 250 REMARK 465 GLU D 251 REMARK 465 ALA D 252 REMARK 465 ASN D 253 REMARK 465 MET D 254 REMARK 465 GLY D 255 REMARK 465 LEU D 256 REMARK 465 ASN D 257 REMARK 465 PRO D 258 REMARK 465 SER D 259 REMARK 465 SER D 260 REMARK 465 PRO D 261 REMARK 465 ASN D 262 REMARK 465 PRO D 458 REMARK 465 HIS D 459 REMARK 465 GLN D 460 REMARK 465 MET D 461 REMARK 465 THR D 462 REMARK 465 GLU F 628 REMARK 465 PRO F 642 REMARK 465 SER F 643 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 SO4 D 503 O HOH D 601 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 436 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 436 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG D 316 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG D 371 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG D 371 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 263 108.29 -51.58 REMARK 500 LEU A 391 52.28 -92.09 REMARK 500 HIS D 288 -8.64 82.10 REMARK 500 ASP D 444 -97.25 -72.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9R0 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9CR D 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 D 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 D 503 DBREF 6A5Y A 244 471 UNP Q96RI1 NR1H4_HUMAN 258 485 DBREF 6A5Y B 744 759 UNP B5MCN7 B5MCN7_HUMAN 534 549 DBREF 6A5Y D 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 6A5Y F 628 643 UNP B5MCN7 B5MCN7_HUMAN 534 549 SEQADV 6A5Y GLU A 432 UNP Q96RI1 CYS 446 ENGINEERED MUTATION SEQADV 6A5Y GLU A 466 UNP Q96RI1 CYS 480 ENGINEERED MUTATION SEQRES 1 A 228 GLU LEU THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE SEQRES 2 A 228 MET ASP SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE SEQRES 3 A 228 THR ASN LYS ILE LEU LYS GLU GLU PHE SER ALA GLU GLU SEQRES 4 A 228 ASN PHE LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL SEQRES 5 A 228 GLN VAL LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE SEQRES 6 A 228 GLN THR LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS SEQRES 7 A 228 GLY SER ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU SEQRES 8 A 228 ILE PHE ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU SEQRES 9 A 228 LEU GLU GLU ARG ILE ARG ASN SER GLY ILE SER ASP GLU SEQRES 10 A 228 TYR ILE THR PRO MET PHE SER PHE TYR LYS SER ILE GLY SEQRES 11 A 228 GLU LEU LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR SEQRES 12 A 228 ALA ILE VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS SEQRES 13 A 228 ASP ARG GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU SEQRES 14 A 228 ASP VAL LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU SEQRES 15 A 228 ASN PRO GLN HIS PHE ALA GLU LEU LEU GLY ARG LEU THR SEQRES 16 A 228 GLU LEU ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU SEQRES 17 A 228 MET SER TRP ARG VAL ASN ASP HIS LYS PHE THR PRO LEU SEQRES 18 A 228 LEU GLU GLU ILE TRP ASP VAL SEQRES 1 B 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 B 16 SER PRO SER SEQRES 1 D 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 D 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 D 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 D 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 D 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 D 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 D 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 D 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 D 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 D 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 D 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 D 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 D 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 D 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 D 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 D 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 D 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 D 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 D 238 HIS GLN MET THR SEQRES 1 F 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 F 16 SER PRO SER HET 9R0 A 501 38 HET SO4 A 502 5 HET 9CR D 501 22 HET PO4 D 502 5 HET SO4 D 503 5 HETNAM 9R0 2-[2-[[3-[2,6-BIS(CHLORANYL)PHENYL]-5-CYCLOPROPYL-1,2- HETNAM 2 9R0 OXAZOL-4-YL]METHOXY]-6-AZASPIRO[3.4]OCTAN-6-YL]-1,3- HETNAM 3 9R0 BENZOTHIAZOLE-6-CARBOXYLIC ACID HETNAM SO4 SULFATE ION HETNAM 9CR (9CIS)-RETINOIC ACID HETNAM PO4 PHOSPHATE ION FORMUL 5 9R0 C28 H25 CL2 N3 O4 S FORMUL 6 SO4 2(O4 S 2-) FORMUL 7 9CR C20 H28 O2 FORMUL 8 PO4 O4 P 3- FORMUL 10 HOH *81(H2 O) HELIX 1 AA1 THR A 246 LYS A 262 1 17 HELIX 2 AA2 PRO A 266 ASN A 271 1 6 HELIX 3 AA3 ASN A 271 GLU A 276 1 6 HELIX 4 AA4 SER A 279 LYS A 304 1 26 HELIX 5 AA5 GLY A 307 LEU A 311 5 5 HELIX 6 AA6 ASP A 312 PHE A 336 1 25 HELIX 7 AA7 GLY A 343 ARG A 353 1 11 HELIX 8 AA8 SER A 358 LYS A 376 1 19 HELIX 9 AA9 THR A 378 LEU A 391 1 14 HELIX 10 AB1 ASP A 400 GLN A 423 1 24 HELIX 11 AB2 GLN A 428 ASN A 457 1 30 HELIX 12 AB3 THR A 462 TRP A 469 1 8 HELIX 13 AB4 LYS B 747 LEU B 753 1 7 HELIX 14 AB5 PRO D 231 GLU D 243 1 13 HELIX 15 AB6 PRO D 264 ARG D 285 1 22 HELIX 16 AB7 HIS D 288 LEU D 292 5 5 HELIX 17 AB8 PRO D 293 SER D 317 1 25 HELIX 18 AB9 ILE D 318 VAL D 320 5 3 HELIX 19 AC1 ARG D 334 ALA D 340 1 7 HELIX 20 AC2 VAL D 342 LEU D 353 1 12 HELIX 21 AC3 LEU D 353 MET D 360 1 8 HELIX 22 AC4 ASP D 363 PHE D 376 1 14 HELIX 23 AC5 ASN D 385 TYR D 408 1 24 HELIX 24 AC6 GLY D 413 LEU D 420 1 8 HELIX 25 AC7 LEU D 420 ILE D 442 1 23 HELIX 26 AC8 ASP D 448 GLU D 456 1 9 HELIX 27 AC9 HIS F 630 GLU F 639 1 10 SHEET 1 AA1 2 GLY D 323 LEU D 325 0 SHEET 2 AA1 2 HIS D 331 HIS D 333 -1 O VAL D 332 N ILE D 324 SITE 1 AC1 18 MET A 265 THR A 270 ILE A 273 LEU A 287 SITE 2 AC1 18 THR A 288 ALA A 291 MET A 328 PHE A 329 SITE 3 AC1 18 SER A 332 ILE A 335 PRO A 341 HIS A 344 SITE 4 AC1 18 LEU A 348 TYR A 369 HIS A 447 TRP A 454 SITE 5 AC1 18 HOH A 608 HOH A 615 SITE 1 AC2 3 ARG A 264 PRO A 266 GLN A 267 SITE 1 AC3 11 ILE D 268 ALA D 271 GLN D 275 TRP D 305 SITE 2 AC3 11 PHE D 313 ARG D 316 LEU D 326 ALA D 327 SITE 3 AC3 11 ILE D 345 CYS D 432 HOH D 615 SITE 1 AC4 5 GLN D 411 PRO D 412 GLY D 413 ARG D 414 SITE 2 AC4 5 LYS D 417 SITE 1 AC5 4 ASN A 444 ARG D 348 SER D 427 HOH D 601 CRYST1 83.380 83.380 161.630 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011993 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006187 0.00000